Advocacy News

The draft 2027 Medicare Physician Fee Schedule has been released, and comments on it are due to CMS by Sept. 14. Join the Academy in making your voice heard. See what's at stake for ophthalmology.

The Centers for Medicare and Medicaid Services’ (CMS) proposed 2027 rule would sunset Traditional MIPS, mandate MVP reporting, and add a core measure requirement. Here's what you need to know.

While cost category concerns remain, The Academy's clinical data registry again helped our members achieve strong performance in the Merit-Based Incentive Payment System (MIPS).

The Academy partnered with ASOPRS and NANOS to submit formal written comments to five Medicare administrative contractors on proposed coverage policies for botulinum toxin injections that could override your clinical judgment on treatment decisions.

Applications must be submitted on CMS' Quality Payment Program webpage by 8 p.m. ET on Dec. 31.

Ophthalmologists should continue buying and billing for eye drugs the same way. If patients' out-of-pocket costs go down, the amount Medicare pays physicians will go up to match.

The Medicare Payment Advisory Commission (MedPAC) modified previous years' recommendations but still recognizes the need for an annual payment update.

Thanks to persistent Academy advocacy, CMS is keeping 2026 MIPS changes minimal while the IRIS Registry maintains its data registry status — protecting you from increased burden as you work to maximize your quality scores.

The Academy’s team of health policy experts have analyzed finalized Medicare policies slated to begin Jan. 1, 2026, and outline the details of the most controversial policies. We are running out of time for Congress to act and stop these policies from harming your patients. Act today.

The final rule could affect about 4,000 hospital outpatient departments and 6,000 ambulatory surgical centers (ASC).